Gilteritinib: The Story of a Proceeding Success into Hard-to-Treat <i>FLT3</i>-Mutated AML Patients

by Matteo Molica, Salvatore Perrone, Marco Rossi
Published 2023-05-01

Prognostic Significance of Transcript-Type BCR‐ABL1 in Chronic Myeloid Leukemia

by matteo molica, elisabetta abruzzese, massimo breccia
Published 2020-08-01

Immunotherapy with Monoclonal Antibodies for Acute Myeloid Leukemia: A Work in Progress

by Matteo Molica, Salvatore Perrone, Costanza Andriola, Marco Rossi
Published 2023-10-01

Chimeric Antigen Receptor T-Cell Therapy in Acute Myeloid Leukemia: State of the Art and Recent Advances

by Martina Canichella, Matteo Molica, Carla Mazzone, Paolo de Fabritiis
Published 2023-12-01

Insights into the optimal use of ponatinib in patients with chronic phase chronic myeloid leukaemia

by Matteo Molica, Emilia Scalzulli, Gioia Colafigli, Robin Foà, Massimo Breccia
Published 2019-02-01

Venetoclax: A Game Changer in the Treatment of Younger AML Patients?

by Matteo Molica, Salvatore Perrone, Vincenzo Federico, Caterina Alati, Stefano Molica, Marco Rossi
Published 2023-12-01

TP53 Mutations in Acute Myeloid Leukemia: Still a Daunting Challenge?

by Matteo Molica, Carla Mazzone, Pasquale Niscola, Paolo de Fabritiis, Paolo de Fabritiis
Published 2021-02-01

CPX-351: An Old Scheme with a New Formulation in the Treatment of High-Risk AML

by Matteo Molica, Salvatore Perrone, Carla Mazzone, Laura Cesini, Martina Canichella, Paolo de Fabritiis
Published 2022-06-01

Treatment free remission in chronic myeloid leukemia: Lights and shadows

by Matteo Molica, Nelida I. Noguera, Malgorzata Monika Trawinska, Giovanni Martinelli, Claudio Cerchione, Elisabetta Abruzzese
Published 2020-09-01

CD33 Expression and Gentuzumab Ozogamicin in Acute Myeloid Leukemia: Two Sides of the Same Coin

by Matteo Molica, Salvatore Perrone, Carla Mazzone, Pasquale Niscola, Laura Cesini, Elisabetta Abruzzese, Paolo de Fabritiis
Published 2021-06-01

Case Report: Very Late, Atypical Extra-Medullary Relapse in a Patient With Acute Promyelocytic Leukemia (APL) Rescued With a Transplant-Free Approach

by Matteo Molica, Carla Mazzone, Tiziana Ottone, Pasquale Niscola, Elisabetta Abruzzese, Stefano Fratoni, Maria Teresa Voso, Paolo de Fabritiis, Paolo de Fabritiis
Published 2021-06-01

Life-threatening autoimmune hemolytic anemia and idiopathic thrombocytopenic purpura: successful seletive splenic artery embolization

by matteo molica, Fulvio Massaro, Giorgia Annechini, Erminia Baldacci, Gianna maria D'elia, Riccardo Rosati, Silvia maria trisolini, Paola Volpicelli, Robin Foà, Saveria Capria
Published 2016-04-01

Identification of Predictive Factors for Overall Survival and Response during Hypomethylating Treatment in Very Elderly (≥75 Years) Acute Myeloid Leukemia Patients: A Multicenter R...

by Matteo Molica, Carla Mazzone, Pasquale Niscola, Ida Carmosino, Ambra Di Veroli, Cinzia De Gregoris, Fabrizio Bonanni, Salvatore Perrone, Natalia Cenfra, Luana Fianchi, Anna Lina Piccioni, Antonio Spadea, Giovanni Luzi, Andrea Mengarelli, Laura Cudillo, Luca Maurillo, Livio Pagano, Massimo Breccia, Luigi Rigacci, Paolo De Fabritiis
Published 2022-10-01